| 摘要 |
The invention concerns pyrimidine derivatives of Formula (I) wherein m is 0-3 and each R<1> is a group such as hydroxy, halogeno, trifluoromethyl and cyano; R<3> is hydrogen, halogeno or (1-6C)alkyl; n is 0-2 and each R<2> is a group such as hydroxy, halogeno, trifluoromethyl and cyano; p is 0-4; and Q<1> is aryl or heteroaryl; or pharmaceutically acceptable salts or in vivo cleavable esters thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.
|
